|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/47 | |
| A61K 31/557 | |||
| A61P 27/06 |
| (11) | Number of the document | 2976080 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14719999.6 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2016-01-27 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/029335 |
| Date | 2014-03-14 |
| (87) | Number | WO 2014/144781 |
| Date | 2014-09-18 |
| (30) | Number | Date | Country code |
| 201361787883 P | 2013-03-15 | US |
| (72) |
KOPCZYNSKI, Casey, US
LIN, Cheng-wen, US
STURDIVANT, Jill, Marie, US
DELONG, Mitchell, A., US
|
| (73) |
Aerie Pharmaceuticals, Inc.,
7020 Kit Creek Road, Suite 270 P. O. box 12320, Research Triangle Park, NC 27709,
US
|
| (54) | CONJUGATES OF ISOQUINOLINE COMPOUNDS AND PROSTAGLANDINS |
| CONJUGATES OF ISOQUINOLINE COMPOUNDS AND PROSTAGLANDINS |